News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
New Zealand Biotech Proacta Names Paul Cossum President And Chief Executive
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Proacta Inc., an oncology drug discovery company, has appointed Paul Cossum as president and chief executive.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Obesity
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
October 14, 2026
·
3 min read
·
Tristan Manalac
Business
J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutback
October 14, 2026
·
1 min read
·
Jef Akst
China
European biotech leaders split on US-China fight for deal dominance, survey finds
October 14, 2026
·
2 min read
·
Nick Paul Taylor
Obesity
Roche expands obesity R&D footprint with Rona deal worth $1B+
October 13, 2026
·
2 min read
·
Michael Gibney
